--- title: "Simulations Plus|8-K:2025 财年营收 79.1 百万美元超过预期" type: "news" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/262233861.md" published_at: "2025-10-22T11:52:10.000Z" --- # Simulations Plus|8-K:2025 财年营收 79.1 百万美元超过预期 营收:截至 2025 财年,公布值为 79.1 百万美元,市场一致预期值为 78.09 百万美元,超过预期。 ### 财务指标总结 #### 2025 财年初步结果 - **收入**: $79.1M - **收入增长**: 13% - **软件占比**: 58% - **调整后的 EBITDA 利润率**: 28% - **调整后的稀释每股收益**: $1.03 #### 2026 财年指导 - **收入**: $79M – $82M - **收入增长**: 0 – 4% - **软件占比**: 57 – 62% - **调整后的 EBITDA 利润率**: 26 – 30% - **调整后的稀释每股收益**: $1.03 - $1.10 #### 前瞻性声明 Simulations Plus, Inc. 预计在 2025 财年尽管面临市场挑战,仍能实现修订后的指导目标。公司计划在 2026 财年继续推进创新,推出新产品愿景,提升软件功能,深化平台整合,并推进 AI 能力。 ### Related Stocks - [SLP.US - Simulations Plus](https://longbridge.com/zh-CN/quote/SLP.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Herald Investment Management Ltd Makes New $3.02 Million Investment in Simulations Plus, Inc. $SLP | Herald Investment Management Ltd has made a new investment of approximately $3.02 million in Simulations Plus, Inc. (NAS | [Link](https://longbridge.com/zh-CN/news/276001912.md) | | Simulations Plus AGM: Shareholders Approve All Proposals, Back Annual Say-on-Pay Votes | Simulations Plus held its annual shareholder meeting virtually, chaired by CEO Shawn O’Connor. All four proposals were a | [Link](https://longbridge.com/zh-CN/news/276005355.md) | | Simulations Plus Extends Research Collaborations with FDA and NIEHS | Simulations Plus Inc. has extended its research collaborations with the FDA and NIEHS to support federal research on new | [Link](https://longbridge.com/zh-CN/news/275486385.md) | | Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations \| SLP Stock News | Simulations Plus, Inc. has announced the extension of research collaborations with the U.S. FDA and NIEHS, focusing on c | [Link](https://longbridge.com/zh-CN/news/275377833.md) | | Dir LaVange Files To Sell 866 Of Simulations Plus Inc [SLP] | LaVange Lisa, Director of Simulations Plus Inc, filed a Form 144 with the SEC to sell 866 shares of restricted securitie | [Link](https://longbridge.com/zh-CN/news/268143477.md) | --- > **免责声明**:本文内容仅供参考,不构成任何投资建议。